US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Enzon Pharmaceuticals, Inc.

0.0652

-0.0028-4.19%

Volume:6.00K

Turnover:415.77

Market Cap:4.84M

PE:-1.31

High:0.0710

Open:0.0700

Low:0.0652

Close:0.0681

52wk High:0.1299

52wk Low:0.0310

Shares:74.21M

Float Shares:30.11M

Volume Ratio:0.12

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0497

EPS(LYR):-0.0067

ROE:-5.36%

ROA:-1.87%

PB:-5.24

PE(LYR):-9.74

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Enzon Pharmaceuticals, Inc.

Exchange:

OTCQB

Establishment Date:

1981

Employees:

1

Office Location:

20 Commerce Drive,Suite 135,Cranford,New Jersey,United States

Website:

http://www.enzon.com

Zip Code:

07016

Phone:

Fax:

- -

Introduction:

Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ENZN/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ENZN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENZN\",,,,,undefined,":{"symbol":"ENZN","market":"US","secType":"STK","nameCN":"Enzon Pharmaceuticals, Inc.","latestPrice":0.0652,"timestamp":1771621200000,"preClose":0.06805,"halted":0,"volume":6001,"delay":15,"changeRate":-0.04188096987509192,"floatShares":30114014,"shares":74214603,"eps":-0.049653,"marketStatus":"Market Closed","change":-0.00285,"latestTime":"02-20 16:00:00 EST Delay","open":0.07,"high":0.071,"low":0.0652,"amount":415.7680500000001,"amplitude":0.085231,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.049653,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.06805,"volumeRatio":0.11613909576680605},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENZN\",,,,,undefined,":{"symbol":"ENZN","floatShares":30114014,"roa":"-1.87%","roe":"-5.36%","lyrEps":-0.006696,"volumeRatio":0.11613909576680605,"shares":74214603,"dividePrice":0,"high":0.071,"amplitude":0.085231,"preClose":0.06805,"low":0.0652,"week52Low":0.031,"pbRate":"-5.24","week52High":0.1299,"institutionHeld":0,"latestPrice":0.0652,"eps":-0.049653,"divideRate":0,"volume":6001,"delay":15,"ttmEps":-0.049653,"open":0.07,"prevYearClose":0.0379,"prevWeekClose":0.0684,"prevMonthClose":0.0789,"prevQuarterClose":0.0379,"fiveDayClose":0.0718,"twentyDayClose":0.0501,"sixtyDayClose":0.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENZN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-09-30","symbol":"ENZN","amount":0.12,"name":"恩宗药业","recordDate":"2019-10-15","payableDate":"2019-10-01","currency":"USD","type":"dividend","dateTimestamp":1569816000000},{"market":"US","date":"2019-02-20","symbol":"ENZN","amount":0.06,"name":"恩宗药业","recordDate":"2019-03-21","payableDate":"2019-02-21","currency":"USD","type":"dividend","dateTimestamp":1550638800000},{"market":"US","date":"2017-09-29","symbol":"ENZN","amount":0.15,"name":"恩宗药业","recordDate":"2017-09-28","payableDate":"2017-08-30","currency":"USD","type":"dividend","dateTimestamp":1506657600000},{"market":"US","date":"2016-12-30","symbol":"ENZN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1483074000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENZN\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-13","recordDate":"2016-11-28","paymentDate":"2016-12-12","value":0.15,"currency":"USD"},{"executeDate":"2017-09-29","recordDate":"2017-08-30","paymentDate":"2017-09-28","value":0.15,"currency":"USD"},{"executeDate":"2019-02-20","recordDate":"2019-02-21","paymentDate":"2019-03-21","value":0.06,"currency":"USD"},{"executeDate":"2019-09-30","recordDate":"2019-10-01","paymentDate":"2019-10-15","value":0.12,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENZN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":269599,"yearFounded":1981,"employeeNum":1,"address":"20 Commerce Drive,Suite 135,Cranford,New Jersey,United States","zipCode":"07016","officePhone":"732 980 4500"},"stockCompanyDetail":{"websiteUrl":"http://www.enzon.com","stockEarnings":[{"period":"1week","weight":0.0926},{"period":"1month","weight":-0.0788},{"period":"3month","weight":-0.0604},{"period":"6month","weight":0.0213},{"period":"1year","weight":-0.0451},{"period":"ytd","weight":-0.0679}],"description":"Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.","exchange":"OTCQB","name":"Enzon Pharmaceuticals, Inc.","nameEN":"Enzon Pharmaceuticals, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ENZN\",market:\"US\",,,undefined,":null}}